This is a preview of subscription content, log in via an institution to check access.
Notes
"Demographic details of two patients (35 and 43 year-old women) were obtained through personal communication with the author. However, the author did not provide details of other two patients."
Reference
Holbrook K, et al. Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series. Cancer 126: 523-530, No. 3, Feb 2020. Available from: URL: http://doi.org/10.1002/cncr.32547
Rights and permissions
About this article
Cite this article
Binimetinib/encorafenib. Reactions Weekly 1794, 48 (2020). https://doi.org/10.1007/s40278-020-75844-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-75844-3